HighTide, ProSciento team-up against diabetes and NAFLD

HighTide, ProSciento team-up against diabetes and NAFLD

HighTide, ProSciento team-up against diabetes and NAFLD

August 1, 2016 – HighTide Biopharmaceutical and ProSciento Inc., announced a partnership focused on developing therapies for diabetes and nonalcoholic fatty liver disease, according to a press release.

Read the full article at Healio ยป